Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459773 (3,3-dimethyl-2-{2-[(3R)-3-methylmorpholin-4-yl]-8-...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer AG Curated by ChEMBL | Assay Description Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[... | J Med Chem 63: 7293-7325 (2020) Article DOI: 10.1021/acs.jmedchem.0c00369 BindingDB Entry DOI: 10.7270/Q29C71ZT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM50427326 (CHEMBL2325697) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer AG Curated by ChEMBL | Assay Description Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[... | J Med Chem 63: 7293-7325 (2020) Article DOI: 10.1021/acs.jmedchem.0c00369 BindingDB Entry DOI: 10.7270/Q29C71ZT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268208 (US10772893, Example 241 | US11529356, Example 241 ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.06 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268208 (US10772893, Example 241 | US11529356, Example 241 ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.06 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268208 (US10772893, Example 241 | US11529356, Example 241 ...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.06 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268080 (2-[(3R)-3-methylmorpholin-4-yl]-4-(3-methyl-1,2-ox...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.74 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459603 (US10772893, Example 112 | US11529356, Example 112) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.74 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459603 (US10772893, Example 112 | US11529356, Example 112) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.74 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459573 (US10772893, Example 82 | US11529356, Example 82) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268050 (2-[(3R)-3-methylmorpholin-4-yl]-4-[4-(methylsulfon...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459573 (US10772893, Example 82 | US11529356, Example 82) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459573 (US10772893, Example 82 | US11529356, Example 82) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer AG Curated by ChEMBL | Assay Description Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[... | J Med Chem 63: 7293-7325 (2020) Article DOI: 10.1021/acs.jmedchem.0c00369 BindingDB Entry DOI: 10.7270/Q29C71ZT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268038 (4-(1-methyl-1H-imidazol-5-yl)-2-[(3R)-3-methylmorp...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.17 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459561 (US10772893, Example 70 | US11529356, Example 70) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.17 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459561 (US10772893, Example 70 | US11529356, Example 70) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.17 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268037 (4-(1-ethyl-1H-pyrazol-5-yl)-2-[(3R)-3-methylmorpho...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.34 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459560 (US10772893, Example 69 | US11529356, Example 69) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.34 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459560 (US10772893, Example 69 | US11529356, Example 69) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.34 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459574 (US10772893, Example 83 | US11529356, Example 83) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.38 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268051 (N-(2,2-dimethylpropyl)-N-methyl-2-[(3R)-3-methylmo...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.38 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459574 (US10772893, Example 83 | US11529356, Example 83) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.38 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459562 (US10772893, Example 71 | US11529356, Example 71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.65 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268039 (2-{2-[(3R)-3-methylmorpholin-4-yl]-8-(1H-pyrazol-5...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.65 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459562 (US10772893, Example 71 | US11529356, Example 71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.65 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268081 (4-(1-ethyl-3-methyl-1H-pyrazol-5-yl)-2-[(3R)-3-met...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.71 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459604 (US10772893, Example 113 | US11529356, Example 113) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.71 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459604 (US10772893, Example 113 | US11529356, Example 113) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.71 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268040 (4-(2,3-difluorophenyl)-2-[(3R)-3-methylmorpholin-4...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.33 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459563 (US10772893, Example 72 | US11529356, Example 72) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.33 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459563 (US10772893, Example 72 | US11529356, Example 72) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.33 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459517 (US10772893, Example 26 | US11529356, Example 26) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.36 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM267994 (4-(4-methanesulphonylphenyl)-2-((R)-3-methylmorpho...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.36 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459517 (US10772893, Example 26 | US11529356, Example 26) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.36 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268067 (2-[(3R)-3-methylmorpholin-4-yl]-4-(3-methyl-2-thie...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.38 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268067 (2-[(3R)-3-methylmorpholin-4-yl]-4-(3-methyl-2-thie...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.38 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268067 (2-[(3R)-3-methylmorpholin-4-yl]-4-(3-methyl-2-thie...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.38 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268219 (US10772893, Example 252 | US11529356, Example 252 ...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.45 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268219 (US10772893, Example 252 | US11529356, Example 252 ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.45 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268219 (US10772893, Example 252 | US11529356, Example 252 ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.45 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459575 (US10772893, Example 84 | US11529356, Example 84) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.60 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268052 ((1-{2-[(3R)-3-methylmorpholin-4-yl]-8-(1H-pyrazol-...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.60 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459575 (US10772893, Example 84 | US11529356, Example 84) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.60 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268217 (US10772893, Example 250 | US11529356, Example 250 ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.62 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268217 (US10772893, Example 250 | US11529356, Example 250 ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.62 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268217 (US10772893, Example 250 | US11529356, Example 250 ...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.62 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459564 (US10772893, Example 73 | US11529356, Example 73) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.71 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US10772893 (2020) BindingDB Entry DOI: 10.7270/Q2T43X50 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM459564 (US10772893, Example 73 | US11529356, Example 73) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.71 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268041 (4-[2-methyl-6-(methylsulfonyl)pyridin-3-yl]-2-[(3R...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.71 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ATR-interacting protein/Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268172 (US10772893, Example 204 | US11529356, Example 204 ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.76 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | Citation and Details BindingDB Entry DOI: 10.7270/Q2474FQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM268172 (US10772893, Example 204 | US11529356, Example 204 ...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.76 | n/a | n/a | n/a | n/a | 7.0 | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo... | US Patent US9549932 (2017) BindingDB Entry DOI: 10.7270/Q27S7QSC | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1543 total ) | Next | Last >> |